GM's new CCU architecture rolls out from the 2028 Cadillac ESCALADE IQ to the Silverado, with OnStar AI Assistant and ...
Canadian mutual insurer automates Guidewire InsuranceSuite and ProducerEngage testing in a quality transformation, with ...
Bristol Myers Squibb (NYSE:BMY) has entered multi year AI drug development partnerships with Pathos AI and Tempus AI. The ...
A development study combined deep learning segmentation with persistent homology analysis of optic nerve head tissues, ...
Pathos AI, a clinical-stage AI and technology company advancing its own therapeutic pipeline, today announced multi-year strategic collaborations with Bristol Myers Squibb (NYSE: BMY, “BMS”) and ...
This approach uses a fixed-depth quantum circuit applied to an initial Floquet eigenstate, a construction made possible by ...
CHO expression and rapid characterization help close the gap between computational design and experimental validation · ...
Oct 23 (Reuters) - Pathos AI said on Friday it had entered into a collaboration with Bristol Myers Squibb and Tempus AI to develop artificial intelligence tools for drug development in Alzheimer's ...
Moonshot AI has actively filtered and pruned cyber-related training data for its open-weight Kimi K3.1 Pro model to ...
Spread the loveThe buzz around artificial intelligence has been nothing short of electrifying. From self-driving cars to ...
Executive Connections, a speed networking event, brought 24 alumni executives to campus to meet MBA and Specialized Master’s ...
Tech Times on MSN
Loss and damage fund gave Nepal $20M; World Court already said states owe reparations
Loss and damage fund Nepal: the Fund for Responding to Loss and Damage voted October 22 to set aside $20 million for Nepal's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results